Stero Biotechs
Company Details
Status: Private
Employees: 1-10
Location:
14 Baruch Hirsh St, Bnei Brak, Israel 5120206, IL
Type:
sample
Technology:
sample
About: STERO, founded in 2017 and headquartered in Israel, is a clinical-stage company committed to the research and development of novel and improved Cannabidiol (CBD) based treatment solutions that will potentially benefit millions of patients by reducing the side effects and the need of steroid therapy.
STERO's extremely wide coverage patent (CBD from any source, in any combination, any dosage, in any delivery system, all for more than 130 diseases by name) was Issued in the US on August 2018 and is pending in main countries around the world.
Stero currently has 3 ongoing clinical trials, 2 phase 2a clinical trials in Crohn's disease, and in Chronic Urticaria (Hives), 1 phase 1/2 clinical trial treating severe covid-19 patients, all covered by Stero's IP & pursuing the FDA drug route, with more in the pipeline.
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
Stero Biotechs | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.